Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
FKY 2-{[(3r,4s)-3-fluoro-1-{[4-(trifluoromethoxy)phenyl]acetyl}piperidin-4-yl]oxy}-5-(1-methyl-1h-imidazol-4-yl)pyridine-3-carboxamide
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 6CZ4   PDBj   RCSB PDB   PDBe
Header : Transferase/Transferase Inhibitor
Title : Structure of the PTK6 kinase domain bound to a type II inhibitor 2-{[(3R,4S)-3-fluoro-1-{[4-(trifluoromethoxy)phenyl]acetyl}piperidin-4-yl]oxy}-5-(1-methyl-1H-imidazol-4-yl)pyridine-3-carboxamide
Release Data : 2018-06-20
Compound :
mol_id molecule chains synonym
1 Protein-tyrosine kinase 6 A Breast tumor kinase,Tyrosine-protein kinase BRK
ec: 2.7.10.2
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Spodoptera frugiperda  (taxid:7108)
gene: PTK6, BRK
Authors : Gajiwala, K.S., Johnson, E., Cronin, C.N.
Keywords : Protein kinase, PTK6, Transferase-Transferase Inhibitor complex
Exp. method : X-RAY DIFFRACTION ( 1.50 Å )
Citation :

Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.

Qiu, L.,Levine, K.,Gajiwala, K.S.  et al.
(2018)  PLoS ONE  13 : e0198374 - e0198374

PubMed: 29879184
DOI: 10.1371/journal.pone.0198374

Chain : A
UniProt : Q13882 (PTK6_HUMAN)
Reaction: EC: Evidence:
Physiological Direction:
ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl- [protein] 2.7.10.2 PROSITE-ProRule:PRU10028, PubMed:12121988, PubMed:27480927, PubMed:27993680
-